Retrospective cohort finds COVID-19 infection linked to proteinuria progression in type 2 diabetes

This retrospective cohort study included 688 patients with type 2 diabetes mellitus (T2DM) confirmed to have COVID-19 infection and 502 pre-pandemic uninfected patients with T2DM as a comparator. The intervention or exposure was COVID-19 infection and overweight/obesity, with the primary outcome being proteinuria progression. However, the main results, including specific numbers or percentages for proteinuria progression, were not reported in the provided text due to truncation, and secondary outcomes, follow-up duration, and setting were also not reported.

Safety and tolerability data, such as adverse events, serious adverse events, and discontinuations, were not reported. The study has limitations noted in the input, including that the results section was not included and text truncation limits data extraction, which reduces the ability to assess findings comprehensively.

Given the retrospective observational design and incomplete evidence, this study cannot establish causality between COVID-19 infection and proteinuria progression in T2DM. Practice relevance was not reported, so clinicians should await more complete data before drawing clinical conclusions.